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Melanocortin-4 receptor (MC4R) mutations cause
dysregulation of energy balance and hyperinsuline-
mia. We have used mouse models to study the
physiological roles of extrahypothalamic MC4Rs.
Re-expression of MC4Rs in cholinergic neurons
(ChAT-Cre, loxTB MC4R mice) modestly reduced
body weight gain without altering food intake and
was sufficient to normalize energy expenditure and
attenuate hyperglycemia and hyperinsulinemia.
In contrast, restoration of MC4R expression in brain-
stem neurons including those in the dorsal motor
nucleus of the vagus (Phox2b-Cre, loxTB MC4R
mice) was sufficient to attenuate hyperinsulinemia,
while the hyperglycemia and energy balance were
not normalized. Additionally, hepatic insulin action
and insulin-mediated suppression of hepatic glucose
productionwere improved in ChAT-Cre, loxTBMC4R
mice. These findings suggest that MC4Rs expressed
by cholinergic neurons regulate energy expenditure
and hepatic glucose production. Our results also
provide further evidence of the dissociation in path-
ways mediating the effects of melanocortins on
energy balance and glucose homeostasis.
INTRODUCTION
Increased energy intake and decreased energy expenditure
contribute to the development of obesity and its comorbidities,
such as type 2 diabetes, making this problem one of the most
topical health issues facing Western society. Alteration in energy
balance is the main determinant of body composition and body
weight, and is coordinated by central nervous system (CNS)
pathways, including the central melanocortin system (Cone,
2005, 2006; Morton et al., 2006). An important component of
this system is the melanocortin-4 receptor (MC4R), which isCell Mexpressed by a number of neurons in the CNS (Mountjoy et al.,
1994; Kishi et al., 2003; Liu et al., 2003). The role of MC4Rs in
regulation of energy balance is demonstrated by severe obesity
in MC4R knockout mice, in which obesity is caused by the
combined effects of increased food intake anddecreased energy
expenditure (Huszar et al., 1997; Chen et al., 2000; Ste Marie
et al., 2000). Importantly, this obesity syndromealso occurs in hu-
mans withMC4Rmutations (Vaisse et al., 1998; Yeo et al., 1998).
The role of melanocortins in regulating energy balance has
also been demonstrated through pharmacologic experiments.
For example, microinjection of nonselective MC3R/MC4R
agonist (MTII) and antagonist (SHU9119) into the fourth ventricle
near the nucleus of the solitary tract (NTS) and dorsal motor
nucleus of the vagus (DMV) or intraparenchymal injection to
dorsal vagal complex (including the DMV and NTS) results in
an alteration in food intake (Grill et al., 1998; Williams et al.,
2000; Zheng et al., 2005). Moreover, recent experiments using
these pharmacologic compounds suggest that the feeding and
the thermogenic effects of MC3R/MC4R stimulation can be
mediated by multiple, anatomically distributed CNS nuclei
(Skibicka and Grill, 2009).
While the importance of MC4R signaling in the regulation of
energy homeostasis is clear, the specific neural populations
responsible for MC4R-mediated regulation of food intake and
energy expenditure are at present only partially identified. Resto-
ration of MC4R expression in specific forebrain areas, such as
the paraventricular nucleus of the hypothalamus (PVH) and
subpopulations of medial amygdala neurons using Sim1-Cre
transgenic mice, significantly reduces (60%) the obesity
characteristic of MC4R deficiency (Balthasar et al., 2005). In
this model, the increased food intake, typical for MC4R muta-
tions, is completely rescued while reduced energy expenditure
is unaffected. Similarly, these mice still display impaired glucose
homeostasis despite marked improvements in body weight and
adiposity. These findings suggest that MC4Rs in the PVH and/or
the amygdala participate in the regulation of food intake but
MC4Rs expressed elsewhere in the CNS might control energy
expenditure (Balthasar et al., 2005).
Extrahypothalamic sites where prominentMC4R expression is
observed include the cholinergic parasympathetic preganglionicetabolism 13, 195–204, February 2, 2011 ª2011 Elsevier Inc. 195
Figure 1. Generation of ChAT-IRES-Cre and Phox2b-Cre BAC
Transgenic Mice
(A) To generatemice expressingCre-recombinase specifically in preganglionic
sympathetic and parasympathetic neurons, an optimized IRES fused toCre re-
combinase was inserted after the stop codon of the ChAT gene using homol-
ogous recombination techniques.
(B) To target Cre expression in preganglionic parasympathetic neurons, a Cre-
recombinase cassette was introduced into the ATG translation start codon of
the Phox2b BAC, using bacteria dependent recombination.
(C) (Left column) GFP immunohistochemistry in ChAT-Cre, Rosa GFP mice.
Prominent GFP activity was observed in dorsal motor nucleus of vagus
(DMV) and in the intermediolateral cell column (IML). (Right column) b-galacto-
sidase immunohistochemistry in Phox2b-Cre, RosalacZ mice. Strong Cre-
mediated lacZ expression was observed in DMV. No immunoreactivity is
observed in IML. Scale bar, 100 mm.
Cell Metabolism
MC4R Re-expression in Cholinergic Neuronsneurons of the DMV (Mountjoy et al., 1994; Kishi et al., 2003;
Liu et al., 2003). Similarly, afferent neurons of the nodose
ganglion that terminate in the NTS express MC4R (Wan et al.,
2008; Gautron et al., 2010). However, the neuronal cell types
expressing MC4R in cell bodies of the NTS (Kishi et al., 2003;
Liu et al., 2003) are currently unknown.
The neurons of the DMV send visceral efferent output to
several internal organs including the pancreas and digestive
tract. In contrast, the NTS receives afferent sensory information
from the viscera through chemosensory neurons and integrates
this with information from descending inputs from the CNS,
providing overall coordination of several digestive and neuroen-
docrine functions (Berthoud and Powley, 1990; Rogers et al.,
1996). Notably, our recent data have shown that several periph-
eral tissues including the liver, the stomach, and the duodenum
are innervated byMC4Rexpressing vagal afferents and efferents
(Gautron et al., 2010).
Another example of extrahypothalamic MC4R expression is
the sympathetic preganglionic neurons of the intermediolateral
nucleus of the thoracic spinal cord (IML), which coexpress
MC4Rs and choline acetyltransferase (ChAT) mRNA (Kishi
et al., 2003). Importantly, IML neurons are also directly inner-
vated by a subset of leptin-activated POMC neurons residing
in the arcuate nucleus (Elias et al., 1998; Swanson and Kuypers,
1980). Postganglionic neurons innervating brown adipose tissue
receive projections from IML, thus providing a pathway to regu-
late energy expenditure and diet-induced thermogenesis (Bam-
shad et al., 1999; Rothwell and Stock, 1984; Lowell and Flier,
1997). Taken together, it is possible that MC4Rs in both cholin-
ergic preganglionic sympathetic and parasympathetic neurons
may participate in the regulation of energy balance and
glucose/insulin homeostasis, but the physiological significance
of these pathways has remained difficult to establish.
To directly assess the role of MC4Rs in these extrahypothala-
mic cholinergic sites, we have generated two mouse models
where MC4R expression is restored specifically in both cholin-
ergic preganglionic parasympathetic (DMV) and sympathetic
(IML) neurons (ChAT-Cre, loxTB MC4R mice) or only in cholin-
ergic preganglionic parasympathetic neurons (Phox2b-Cre,
loxTB MC4R mice). By using these unique genetic tools and
parallel approaches, we dissociated the contributions of MC4-
Rs expressed by sympathetic versus parasympathetic neurons
in the regulation of food intake, energy expenditure, and
glucose/insulin homeostasis.
RESULTS
Generation of ChAT-IRES-Cre and Phox2b-Cre BAC
Transgenic Mice
To target Cre expression to cholinergic preganglionic sympa-
thetic and parasympathetic neurons (ChAT-IRES-Cre mice,
Jackson Laboratories stock #006410), an optimized internal
ribosome entry sequence (IRES) fused to Cre recombinase was
inserted after the stop codon of the ChAT gene (Figure 1A). To
assess the expression pattern of Cre activity, chimeric ChAT-
IRES-Cremicewere crossedwith RosaGFP reportermice, which
express GFP after Cre-mediated deletion of a loxP-flanked
transcriptional blocker (Jackson Laboratories stock #004077).
Strong GFP activity was found in the preganglionic parasympa-196 Cell Metabolism 13, 195–204, February 2, 2011 ª2011 Elsevier Inthetic neurons of the DMV and in the sympathetic preganglionic
neurons in the IML of the thoracic spinal cord (Figure 1C), sites
which endogenously express ChAT mRNA (Kishi et al., 2003).
Expectedly, we also observed GFP expression in other known
cholinergic CNS sites including the nucleus basalis, medial
septum, vertical diagonal band of broca, laterodorsal tegmental
area (LDT), peduncular pontine tegmental nucleus (PPT), nucleus
ambiguous, and cranial nerve nuclei (Armstrong et al., 1983).
To target Cre expression specifically to brainstem autonomic
control neurons (Pattyn et al., 1997; Brunet and Pattyn, 2002)c.
Figure 2. Expression ofMc4rmRNA in ChAT-Cre, loxTB MC4R, and
Phox2b-Cre, loxTB MC4R Mice
(A) Mc4r mRNA in situ hybridization in hindbrain of wild-type mouse. Note
Mc4r mRNA expression in both DMV and NTS.
(B and C) In ChAT-Cre, loxTB MC4R, and Phox2b-Cre, loxTB MC4R mice
Mc4r mRNA is re-expressed specifically in the DMV.
(D)Mc4rmRNA in situ hybridization in wild-typemice IML of the thoracic spinal
cord.
(E) In ChAT-Cre, loxTB MC4R mice, Mc4r mRNA is re-expressed in rostral-
caudal axis of longitudinal section of thoracic IML (arrowheads), comparably
to wild-type mice (D).
(F) In Phox2b-Cre mice, Mc4r mRNA is not re-expressed in IML. Scale bar,
100 mm.
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a BAC clone containing the Phox2b locus flanked by >75 Kb of
genomic DNA at both the 30 and 50 ends of the gene was used
to drive Cre recombinase expression transgenically (Figure 1B).
Phox2b-Cre BAC transgenic mice were crossed with a R26R
b-galactosidase (lacZ) reporter mouse line (Jackson Laborato-
ries stock #003309) tomap the expression pattern of Cre-recom-
binase. Cre-activated lacZ expression was detected in parasym-
pathetic preganglionic neurons of the DMV, as expected
(Figure 1C), and in other brachial and visceral motor neurons
(data not shown). Importantly, expression of lacZ was not
observed in preganglionic sympathetic neurons of the truncal
spinal cord (Figure 1C). Similarly, Cre-activated lacZ expression
in other CNS sites was clearly below the level required for the
recombination (data not shown). Furthermore, although Phox2b
is expressed by several subtypes of neurons during develop-
ment (Pattyn et al., 1997), we did not detect Phox2b-Cre-acti-
vated reporter expression in peripheral ganglia (such as
postganglionic sympathetic and parasympathetic ganglia,
dorsal root ganglia, and enteric nervous system) or peripheral
tissues such as liver, pancreas, muscle, or white and brown
adipose tissue (data not shown).
Double immunohistochemistry for ChAT and lacZ revealed
strong Cre-activated reporter expression specifically in cholin-
ergic preganglionic neurons of the DMV (see Figure S1 available
online). In contrast, only a few lacZ-labeled cells were seen in the
NTS and area postrema. Importantly, cholinergic preganglionic
sympathetic neurons of the IML were devoid of Cre-immunore-
activity (Figure S1).Re-expression ofMc4r mRNA in Cholinergic
Preganglionic Sympathetic versus Parasympathetic
Neurons
We have previously shown that both cholinergic sympathetic
and parasympathetic preganglionic neurons express MC4-Rs,
suggesting that both of these neuronal populations might
mediate neuroendocrine, autonomic, and behavioral effects of
melanocortins (Kishi et al., 2003). To study the role of MC4R
signaling in cholinergic neurons, we have used mice with
a loxP-modified, null Mc4r allele (loxTB MC4R mice), an allele
which can be reactivated by Cre-recombinase (Balthasar et al.,
2005). To dissociate the roles of MC4Rs on sympathetic versus
parasympathetic preganglionic neurons, loxTBMC4Rmicewere
crossed with ChAT-IRES-Cre (ChAT-Cre, loxTB MC4R) and
Phox2b-Cre BAC transgenic (Phox2b-Cre, loxTB MC4R) mice.
To analyze Mc4r mRNA re-expression, in situ hybridization
was performed on ChAT-Cre, loxTB MC4R, and Phox2b-Cre,
loxTB MC4R mice (Figure 2). In ChAT-Cre, loxTB MC4R mice,
Mc4r mRNA expression was restored in the full rostrocaudal
axis of DMV and in the thoracic spinal cord, including the IML,
the areas which endogenously express MC4Rs in wild-type
mice (Figures 2B and 2E).
Consistently with limited NTS Cre expression in Phox2b-Cre,
loxTB MC4R mice (Figure S1), Mc4r mRNA re-expression was
seen mainly in preganglionic parasympathetic neurons of the
DMV, and with low levels in NTS (Figure 2C). Importantly, Mc4r
mRNA was not re-expressed in sympathetic preganglionic
neurons in the IML (Figure 2F).Cell MMC4R-Mediated Effects in Cholinergic Neurons on Body
Weight and Composition
Re-expression of MC4Rs in cholinergic neurons had a small but
significant effect on body weight (Figure 3A). Starting from
6–8 weeks of age, ChAT-Cre, loxTB MC4R mice were approxi-
mately 10% leaner compared to homozygous loxTB MC4
mice, but were still markedly obese compared to wild-type
control mice. Wild-type mice containing a ChAT-Cre transgene
did not show this body weight phenotype, indicating that the
transgene itself does not negatively affect body weight gain
(data not shown). To determine the origin of increased body
weight, body composition was studied in more detail using
NMR in 7- to 8-week-old WT, loxTB MC4R, and ChAT-Cre,
loxTB MC4R mice (Figures 3C and 3D). As shown previously,
the increased body weight in loxTB MC4R mice arose both
from increased body fat and lean body mass (Balthasar et al.,
2005). Notably, although ChAT-Cre, loxTB MC4R mice had
markedly higher body fat content in contrast to wild-type
mice, they had significantly reduced adiposity in comparison
to loxTB MC4Rmice (Figure 3C). In contrast to ChAT-Cre, loxTB
MC4R mice, reactivation of MC4R signaling in preganglionic
parasympathetic neurons in Phox2b-Cre, loxTB mice was not
sufficient to affect body weight or composition (Figures 3B,
3F, and 3G).
SinceMC4Rs are known to regulate body length (Huszar et al.,
1997; Balthasar et al., 2005), snout-to-anus length was
measured in 7- to 8-week-old male mice (Figures 3E and 3H).
The body length of loxTB MC4R, ChAT-Cre, loxTB MC4R, and
Phox2b-Cre, loxTB MC4R mice was comparable, and signifi-
cantly higher in comparison to WT mice. Thus, reactivation of
MC4R receptors in cholinergic sympathetic or parasympathetic
preganglionic neurons is not sufficient to suppress linear growth
characteristic of MC4R deficiency.etabolism 13, 195–204, February 2, 2011 ª2011 Elsevier Inc. 197
Figure 3. Body Weight Curve and Body
Composition in ChAT-Cre, loxTB MC4R,
and Phox2b-Cre, loxTB MC4R Mice
(A) Body weight curve in ChAT-Cre, loxTB MC4R
male mice (n = 7–11/group, mean ± SEM,
*p < 0.05, **p < 0.01).
(B) Body weight curve in Phox2b-Cre, loxTB
MC4R mice (n = 6–12/group, mean ± SEM).
(C–E) Body composition and body length in 7- to
8-week old ChAT-Cre, loxTB MC4R male mice
(8–14/group, mean ± SEM, *p < 0.05, ***p < 0.001).
(F–H) Body composition and body length in 7- to
8-week old Phox2b-Cre, loxTB MC4R mice (n =
7–10/group, mean ± SEM, ***p < 0.001).
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MC4R Re-expression in Cholinergic NeuronsIn summary, reactivation of melanocortin-4 signaling in
sympathetic preganglionic, but not in parasympathetic neurons,
plays a small but significant role in regulation of body weight and
body composition.
MC4R-Mediated Effects in Cholinergic Neurons on Food
Intake and Energy Expenditure
We next monitored feeding behavior and energy expenditure to
study the effects of MC4R re-expression on cholinergic pregan-
glionic sympathetic versus parasympathetic neurons on energy
balance. Weekly food intake did not differ between wild-type
and ChAT-Cre littermates, indicating that the transgene itself
does not have an effect on feeding behavior. In contrast to
wild-type control mice, loxTB MC4R, ChAT-Cre, loxTB MC4R,
and Phox2b-Cre, loxTB MC4Rmice displayed significant hyper-
phagia (Figures 4A and 4D). Importantly, increased food intake
typical for loxTBMC4Rmice was not altered in ChAT-Cre, loxTB
MC4R, or Phox2b-Cre mice. This suggests that re-expressing
MC4Rs solely in cholinergic preganglionic sympathetic or para-
sympathetic neurons is not sufficient to affect melanocortin-
mediated regulation of food intake.
Since reactivation ofMC4Rs in cholinergic neurons had a small
effect on body weight without changes in food intake, we also
analyzed energy expenditure. As an assessment of energy
expenditure, oxygen consumption was measured in 6- to
7-week-old males using integrated indirect calorimetry (TSE
Systems) (Figures 4B, 4C, 4E, and 4F). To exclude the possibility198 Cell Metabolism 13, 195–204, February 2, 2011 ª2011 Elsevier Inc.that changes in body composition would
affect the differences in metabolic rate,
energy expenditure measurements were
also analyzed from weight-matched
loxTB MC4R, ChAT-Cre, loxTB MC4R,
and Phox2b-Cre, loxTB MC4R mice
(Figure S2).
Notably, ChAT-Cre, loxTB MC4R mice
(Figures 4B and 4C), but not Phox2b-
Cre, loxTB MC4R mice (Figures 4E and
4F), displayed significantly increased
oxygen consumption during the light
and dark period. Similar results were
obtained when the oxygen consumption
was expressed per gram of lean body
mass (Figure S2) or when the data were
expressed on a total body weight basis(data not shown). Respiratory exchange ratio was similar
between groups. Similarly, locomotor activity did not differ
between genotypes (Figure S2).
Taken together, re-expression of Mc4r mRNA in cholinergic
preganglionic (sympathetic and parasympathetic) neurons
does not affect feeding behavior. Furthermore, MC4Rs specifi-
cally on cholinergic sympathetic preganglionic, but not brain-
stem parasympathetic preganglionic neurons, mediate the
effects of melanocortins on energy expenditure.
MC4R-Mediated Effects in Cholinergic Neurons
on Glucose Homeostasis
To investigate whether re-expression of MC4Rs in cholinergic
preganglionic sympathetic or parasympathetic neurons affects
glucose homeostasis, we monitored blood glucose and insulin
levels in 5- to 6-week-old male mice (Figures 5A–5D). We found
no difference in either glucose or insulin levels between
wild-type, ChAT-Cre, or Phox2b-Cre control littermates,
indicating that transgene itself does not have an effect on
glucose homeostasis (data not shown). Expectedly (Huszar
et al., 1997; Balthasar et al., 2005), loxTB MC4R animals
demonstrated marked hyperglycemia and hyperinsulinemia in
comparison to wild-type mice (Figures 5A–5D). We found that
reactivation of MC4R signaling in cholinergic neurons amelio-
rated both hyperglycemia and hyperinsulinemia (Figures 5A
and 5B). Interestingly, while hyperinsulinemia was clearly atten-
uated in Phox2b-Cre, loxTBMC4Rmice, hyperglycemia was not
Figure 4. Weekly Food Intake and Energy
Expenditure in ChAT-Cre, loxTB MC4R,
and Phox2bCre, loxTB MC4R mice
(A) Weekly food intake in 8-week-old male
ChAT-Cre, loxTB MC4R mice (n = 8–11/group,
mean ± SEM, **p < 0.01).
(B and C) Average oxygen consumption was
calculated for both light (B) and dark (C) periods
in 6- to 7-week old ChAT-Cre, loxTB MC4R mice
(n = 8–9/group, mean ± SEM, *p < 0.05).
(D) Weekly food intake in 8-week-old male
Phox2bCre, loxTB MC4R mice (n = 6–12/group,
mean ± SEM, ***p < 0.001).
(E and F) Energy expenditure in 6- to 7-week-old
Phox2b-Cre, loxTB MC4R during light (E) or dark
(F) cycle (n = 6/group, mean ± SEM).
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observed changes in insulin levels could be due to altered
pancreatic insulin content, we determined the total pancreatic
insulin pool. Total pancreatic insulin content was similar between
the genotypes (Figure S3).
To further characterize the mechanisms underlying dysregula-
tion of glucose and insulin homeostasis, hyperinsulinemic-eugly-
cemic clamp studies were performed in 3-month-old male mice
(Hill et al., 2010). Basal glucose levels were elevated in
ChAT-Cre, loxTB MC4R, and Phox2b-Cre, loxTB MC4R mice
compared to wild-type mice (Figures S4A and S4B). During the
clamp, plasma insulin levels were similarly elevated in all groups
(Figures S4C and S4D). The glucose infusion rate (GIR) required
to maintain euglycemia was markedly reduced in loxTB MC4R
mice compared to wild-type littermates, indicating impaired
whole-body insulin action (Figures 5E and 5F). Notably, in
ChAT-Cre, loxTB MC4Rmice, the GIR was increased compared
to loxTB MC4R mice, indicating improved insulin sensitivity
(Figure 5E). This improvement in insulin sensitivity was not
observed in Phox2b-Cre, loxTB MC4R mice (Figure 5F). Both
basal hepatic glucose production (HPG) and glucose disposal
were increased in loxTB MC4R in comparison to wild-type
mice, consistent with observed hyperglycemia (Figures 5G–5J).
During the clamp, WT mice displayed clear insulin-mediated
suppression of HGP and increased glucose disposal (Figures
5G–5J). Notably, insulin-mediated suppression in HGP was
evident in ChAT-Cre, loxTB MC4R mice. This inhibition was
not observed in Phox2b-Cre, loxTB MC4R animals (Figures 5G
and 5H). Glucose disposal rates during clamp were comparable
and similarly suppressed in ChAT-Cre, loxTB MC4R, and
Phox2b-Cre, loxTB MC4R in comparison to WT littermates
(Figures 5I and 5J). Our data indicate that MC4R expression
specifically in cholinergic sympathetic preganglionic neurons
improves hepatic insulin action compared to the MC4R null
mice. Moreover, our data suggest that MC4R signaling in para-
sympathetic preganglionic neurons alleviates hyperinsulinemia
typical for MC4R deficiency but is not sufficient to normalize
hepatic insulin action. Collectively, our results suggest that
MC4Rs specifically in cholinergic neurons regulate the ability
of insulin to suppress HGP.Cell MDISCUSSION
While the multiple CNS sites expressing MC4Rs have been
described in detail (Kishi et al., 2003; Mountjoy et al., 1994; Liu
et al., 2003), the neuronal populations mediating the antiobesity
and antidiabetic effects of melanocortins remain unclear.
To elucidate the physiologically important sites of MC4R
expression, we usedmice with a loxP-modified, null MC4R allele
(loxTB MC4R mice), which can be reactivated by Cre recombi-
nase (Balthasar et al., 2005). A recent study from our group
revealed a divergence in the melanocortin pathways in the
control of food intake and energy expenditure. We found that
MC4R re-expression in SIM1 neurons in the PVH and subpopu-
lations of medial amygdala neurons in a MC4R null background
completely normalized the increased food intake typical for MC4
null mice. However, this manipulation failed to improve energy
expenditure, and only partially improved glucose homeostasis
(Balthasar et al., 2005). To determine whether MC4Rs on cholin-
ergic preganglionic sympathetic and/or parasympathetic
neurons mediate melanocortin’s effects on food intake, energy
expenditure, and glucosemetabolism, we used Cre/loxP system
to re-express MC4R in these neurons.
MC4R Physiological Roles in Cholinergic Neurons
on Aspects of Body Weight Homeostasis
Our current data demonstrate that re-expression of MC4Rs in
both cholinergic preganglionic sympathetic and parasympa-
thetic neurons is not sufficient to rescue the increased body
length typical for MC4R deficiency but has a small, but signifi-
cant, role in body weight regulation. This reduction in body
weight in ChAT-Cre, loxTB MC4R mice in comparison to loxTB
MC4R mice was due to reduced body fat content.
To determine the mechanisms that contributed to this reduc-
tion in body weight, we measured energy intake and energy
expenditure in ChAT-Cre, loxTB MC4R and Phox2b-Cre, loxTB
MC4R mice. Reactivation of MC4R receptors in both pregangli-
onic cholinergic sympathetic and parasympathetic neurons in
ChAT-Cre, loxTBMC4Rmice or only in preganglionic cholinergic
parasympathetic neurons in Phox2b-Cre, loxTB MC4R mice did
not affect food intake. This finding is very interesting consideringetabolism 13, 195–204, February 2, 2011 ª2011 Elsevier Inc. 199
Figure 5. Glucose and Insulin Metabolism in ChAT-Cre, loxTB MC4R, and Phox2b-Cre, loxTB MC4R Mice
(A and B) Plasma glucose and insulin in fed 5- to 6 week-old male ChAT-Cre, loxTBMC4Rmice (n = 8–12/group, mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001).
(C and D) Plasma glucose and insulin in fed 5- to 6-week-old male Phox2b-Cre, loxTB MC4R mice (n = 11–18/group, mean ± SEM, *p < 0.05, **p < 0.01).
(E) GIR during hyperinsulinemic-euglycemic clamp in chow-fed ChAT-Cre, loxTB MC4R mice (n = 6–7/group, mean ± SEM, *p < 0.05 between WT versus loxTB
MC4R and ChAT-Cre, loxTB MC4R mice, #p < 0.05 between loxTB MC4R versus ChAT-Cre mice).
(F) GIR during hyperinsulinemic-euglycemic clamp in chow-fed Phox2b-Cre, loxTBMC4Rmice (n = 6–7/group, mean ± SEM, *p < 0.05 betweenWT versus loxTB
MC4R and Phox2b-Cre, loxTB MC4R mice).
(G and H) HGP (EndoRa) at basal or hyperinsulinemic conditions (n = 6–7/group, mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001).
(I and J) Glucose disposal rate (Rd) at basal and hyperinsulinemic conditions (n = 6–7/group, mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001).
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MC4R Re-expression in Cholinergic Neuronsa number of studies suggesting a potentially important role for
the MC4R-expressing brainstem neurons in the regulation of
feeding behavior. For example, both POMC neurons and
MC4R are present in the NTS, and animals with NTS lesions
have lower food intake and body weight gain (Palkovits et al.,
1987; Kishi et al., 2003; Mountjoy et al., 1994; Hyde and Miselis,
1983). Furthermore, the direct action of melanocortins has also
been demonstrated through the microinjection of MC3R/MC4R
nonselective agonist MTII and antagonist SHU9119 into the
fourth ventricle near the NTS and DMV, or intraparenchymal
injection to dorsal vagal complex (including the DMV and NTS),
which results in an alteration in food intake (Grill et al., 1998;
Williams et al., 2000; Zheng et al., 2005). Interestingly, the food
intake suppressing effects of hypothalamic POMC activation
can be prevented by MC3R/MC4R antagonist administration to
NTS and its vicinity, suggesting a functional role of hypotha-
lamic-brainstem neuronal projections in the control of feeding
behavior (Zheng et al., 2010). Finally, recent experiments have
suggested that activation of MC4Rs modulates glutamatergic
inputs to the NTS, via mainly excitatory actions on presynaptic200 Cell Metabolism 13, 195–204, February 2, 2011 ª2011 Elsevier InMC4Rs on vagal and nonvagal neurons (Wan et al., 2008). Our
current data complements these pharmacologic findings. Since
our model does not express Cre in all classes of NTS neurons, it
is possible that MC4Rs in noncholinergic NTS neurons regulate
food intake. However, it should be noted that MC4R-bearing
DMV neurons might participate in feeding behavior when
MC4R expression is restored in other sites of the CNS. Future
studies using mouse models with Cre expression targeting the
NTS and vagal afferent pathways are clearly warranted.
A key finding of our study is that re-expression of MC4Rs in
autonomic preganglionic neurons in young ChAT-Cre, loxTB
MC4R mice improves the energy expenditure defect typical of
MC4R deficiency. The most likely neuronal population involved
in MC4R-mediated regulation of energy expenditure is the
sympathetic preganglionic neurons in IML. These cells express
MC4Rs and are directly innervated by a subset of leptin-acti-
vated POMC neurons in the Arc (Elias et al., 1998). Furthermore,
postganglionic neurons innervating brown adipose tissue
receive projections from the IML, thus providing a pathway to
regulate energy expenditure and diet-induced thermogenesisc.
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Flier, 1997). In line with these findings, rescued energy expendi-
ture in ChAT-Cre, loxTB MC4R mice, but not with DMV-specific
MC4R reactivation in Phox2b-Cre, loxTB MC4R mice, indicates
that MC4Rs expressed specifically in the sympathetic pregangli-
onic neurons of the spinal cord contribute to melanocortin’s
effects to regulate energy expenditure.
According to our current results, the observation that body
weight and body composition were partially improved in
ChAT-Cre, loxTB MC4R, but not in Phox2b-Cre, loxTB MC4R,
mice suggest that MC4Rs in sympathetic preganglionic neurons
play a modest role through a yet-undefined effect on energy
expenditure. The observed improvement in energy expenditure
may be mediated by several potential mechanisms, such as
Ca2+ cycling in muscle and brown adipose tissue, induction of
brown adipocytes in white fat, and enhanced proton leaks in
interscapular BAT andmuscle mitochondria (Kozak, 2010). Simi-
larly, other mechanisms, such as the recently described direct
melanocortinergic control of peripheral lipid metabolism via the
sympathetic nervous system, might contribute to reduced fat
content in ChAT-Cre, loxTB MC4Rmice (Nogueiras et al., 2007).
MC4R-Mediated Regulation of Glucose Homeostasis
in Cholinergic Neurons
Several functional studies have suggested that the central mela-
nocortin system regulates insulin secretion, glucose utilization,
and production. First, MC4R null mice display hyperinsulinemia
prior to onset of obesity, and intracerebroventricular (icv) admin-
istration of melanocortin agonist MTII has been shown to
decrease plasma insulin levels in ob/ob and lean mice (Huszar
et al., 1997; Fan et al., 1997). Second, central administration of
melanocortin agonists enhances the actions of insulin on both
glucose uptake and production, while antagonism results in
the opposite effect (Obici et al., 2001). These effects on hepatic
and peripheral insulin action are likely driven by the activation of
central melanocortinergic neurons and are presumably medi-
ated through the autonomic nervous system (Obici et al.,
2001). Finally, mutations in the humanMC4R gene lead to hyper-
insulinemia in comparison to sex- and age-matched obese
control subjects who do not have MC4R mutations (Farooqi
et al., 2003).
In the present study, we found that the selective re-expression
of MC4Rs in both cholinergic preganglionic sympathetic and
parasympathetic neurons reduces hyperglycemia and hyperin-
sulinemia, without changes in the feeding behavior. While hyper-
glycemia was clearly improved in ChAT-Cre, loxTB MC4R mice,
this was not observed in Phox2b-Cre, loxTBmice. Thus, our data
suggest that the effect of melanocortins to suppress blood
glucose levels may be at least in part mediated through
MC4Rs expressed in preganglionic sympathetic neurons.
However, we cannot exclude the possibility that the improve-
ments in hyperglycemia seen in ChAT-Cre, loxTB MC4R mice
might be partially indirect, and mediated by improved body
composition.
Selective re-expression of MC4Rs in DMV resulted in a signif-
icant reduction in plasma insulin levels. This result was unex-
pected, considering the classically described role of vagal
efferent stimulation of the pancreas as a stimulatory signal for
insulin secretion (Ahren, 2000). Since DMV neurons are knownCell Mto be spontaneously active (Travagli et al., 2006), it is tempting
to speculate that re-expression of MC4Rs in cholinergic pregan-
glionic neurons in Phox2b-Cre, loxTB MC4R mice might be
sufficient to suppress this tonic activity through melanocortin-
induced inhibition of DMV neurons, resulting in amelioration of
hyperinsulinemia. Although our results indicate that MC4Rs
signaling in preganglionic parasympathetic neurons is sufficient
to suppress blood insulin levels typical of MC4R deficiency, the
possible contribution of MC4Rs in preganglionic sympathetic
neurons of the IML in the suppression of insulin levels cannot
be ruled out. Importantly, in both ChAT-Cre, loxTB MC4R and
Phox2b-Cre, loxTB MC4R mice the total pancreatic insulin
content was comparable to that of wild-type mice, indicating
that the changes in blood insulin are not mediated by altered
pancreatic insulin production.
Furthermore, our results confirm that central melanocortin
neurons play an important role in regulation of glucose and
insulin homeostasis. For example, the suppression of insulin-
mediated HGP was observed only in ChAT-Cre, loxTB MC4R
mice, indicating that MC4Rs in cholinergic preganglionic sympa-
thetic neurons participate in the regulation of glucose homeo-
stasis by suppressing HGP. These findings agree with recent
observations showing that hepatic muscarinic acetylcholine
receptors and parasympathetic cholinergic outflow are not criti-
cally involved in maintaining glucose homeostasis in mice
(Li et al., 2009). Thus, in line with recent observations underlining
the importance of sympathetic outflow on centrally mediated
regulation of HGP (van den Hoek et al., 2008), our data suggest
that central melanocortin circuits contribute to the regulation of
insulin action andHGP through the sympathetic nervous system.
Future studies to define the specific hepatic insulin signaling
pathways are clearly warranted.
Our data do not exclude the possibility that other efferent,
presumably noncholinergic or melanocortin-independent vagal
pathways may exist which participate in regulation of glucose
homeostasis in liver (Lam et al., 2005; Pocai et al., 2005).Technical Considerations
In this study, we focused our efforts on examining the role of
MC4Rs in extrahypothalamic cholinergic sites, and their involve-
ment on food intake, energy expenditure, and glucose metabo-
lism. One consideration of the genetic approach is that reactiva-
tion of MC4Rs in the MC4R null, loxTB model is dependent on
both the spatial and temporal expression of Cre recombinase.
Thus, we cannot definitively exclude the possibility that develop-
mental compensation for alterations in the timing and pattern of
MC4R expression in this model contributes in part to the meta-
bolic phenotypes observed.
In addition, neuronal subpopulation-specific reactivation of
MC4Rs in the loxTB MC4R model can only determine whether
MC4Rs expressed in those subpopulations are sufficient to
mediate aspects of the regulation of energy balance. However,
it is not possible to determine whether those neurons are the
only site mediating these effects of melanocortins. Thus, here,
we cannot rule out the possibility that MC4Rs also in noncholi-
nergic neurons participate in the regulation of energy expendi-
ture. Indeed, recent pharmacologic experiments suggest that
a certain degree of redundancy exists in melanocortin-mediatedetabolism 13, 195–204, February 2, 2011 ª2011 Elsevier Inc. 201
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2007).
As we have reported in the previous publication, reactivation
of MC4R expression in PVN/amygdala using Sim-1-Cre, loxTB
MC4R mice prevents 60% of the obesity and 100% of the
hyperphagia observed in MC4R null mice (Balthasar et al.,
2005). In the current study, while increased food intake typical
for MC4R null mice was not rescued, reactivation of MC4R
receptors in preganglionic sympathetic neurons only partially
reduced body weight and adiposity. The difference in body
weight between MC4R null mice and ChAT-Cre, loxTB MC4R
mice was 10%. Our data collectively indicate that MC4Rs
expressed on PVH neurons do not regulate energy expenditure
(Balthasar et al., 2005) and that MC4Rs on ChAT neurons do
not regulate food intake (this study). However, we do not believe
in simple additivity of PVH and ChAT neuronmelanocortin-medi-
ated effects, due to the potential existence of aforementioned
redundant pathways.
Other sites whereMC4Rs are possibly reactivated include LDT
and PPT, where we have found coexpression of ChAT immuno-
reactivity and MC4R expression (Kishi et al., 2003; Liu et al.,
2003). These sites are thought to be key components of the
CNS arousal system and play an important role in the regulation
of locomotor activity (Saper et al., 2001; Winn, 2006). Although
we cannot exclude the possibility that MC4R reactivation in
these areas may have effects on energy balance in our models,
we favor the role of sympathetic preganglionic neurons in IML as
mediators of MC4R action on energy expenditure, since we did
not see significant alterations in locomotor activity.
In summary, the present study shows that reactivation of
melanocortin signaling in cholinergic sympathetic preganglionic
neurons is sufficient to increase energy expenditure and
attenuate hyperglycemia, hyperinsulinemia, and HGP without
drastically affecting the hyperphagia or obesity typical of
MC4R deficiency. In contrast, re-expression of MC4Rs in cholin-
ergic preganglionic parasympathetic neurons has no effect on
food intake, energy expenditure, and HGP. Current findings
emphasize the importance of MC4R signaling for glucose and
insulin homeostasis and provide further evidence of the dissoci-
ation in pathways mediating the effects of melanocortin on
energy balance. Moreover, our observations provide information
by which the dysregulation of these autonomic pathways could
contribute to the pathophysiology of type II diabetes.EXPERIMENTAL PROCEDURES
Generation of ChAT-IRES-Cre and Phox2b-Cre BAC Transgenic
Mice
For detailed description, see the Supplemental Experimental Procedures.
Briefly, to target Cre expression specifically to cholinergic neurons
(ChAT-IRES-Cre mice), an optimized IRES fused to Cre recombinase followed
by a neomycin resistance cassette that is flanked by Flp recombinase recog-
nition sites (FRT sites) was inserted after the ChAT stop codon. Generation of
genetically modified mice and removal of Flp-flanked neomycin cassette were
as previously described (Tong et al., 2007).
To target Cre expression in preganglionic parasympathetic neurons, a BAC
clone containing the Phox2b locus flanked by >75 Kb of genomic DNA at both
the 30 and 50 ends of the gene was used to drive Cre recombinase expression.
A Cre recombinase cassette was introduced into the ATG translation start
codon of the Phox2b BAC, using bacteria-dependent recombination. Briefly,
a Cre expression cassette was coupled to 90 bp of DNA homologous to the202 Cell Metabolism 13, 195–204, February 2, 2011 ª2011 Elsevier InPhox2b locus 50 of the Phox2b ATG and to DNA directly 30 of the ATG by
PCR. This targeting fragment was then electroporated into recombination
competent bacteria harboring the Phox2b BAC. Recombinants were identified
by positive antibiotic selection and injected into C57Bl/6J mouse pronuclei to
produce independent founder lines. All animal procedures were conducted in
accordance with UTSW Southwestern Institutional Animal Care and Use
Committee guidelines and those of the Association for Assessment and
Accreditation of Laboratory Animal Care.
In Situ Hydridization
In situ hybridization for mouse Mc4r mRNA was performed as previously
described (Balthasar et al., 2005). The following primers were used to generate
mouse-specificMc4r cDNA probe: F, 50-ATTACCTTGACCATCCTGAT-30, and
R, 50-ATGTCAATTCATAACGCCCA-30.
Immunohistochemistry
ChAT-IRES-Cre and Phox2b-Cre BAC transgenic mice were crossed with
Rosa-GFP (Jackson Laboratories, stock #004077) and R26R lacZ (Jackson
Laboratories stock #003309) reporter mouse lines, respectively. Double trans-
genic offspring were perfused transcardially with 10% formalin, and the brains
and spinal cord were sectioned on a sliding microtome and immunohisto-
chemistry was performed using same protocols and antibodies as previously
described (Balthasar et al., 2005).
Energy Expenditure
For detailed description, see the Supplemental Experimental Procedures.
Briefly, energy expenditure (O2 consumption) was measured by indirect
calorimetry using TSE Labmaster monitoring system (TSE Systems GmbH,
Bad Homburg, Germany). For metabolic measurements, 6- to 7-week old
male mice were used. Average oxygen consumption was calculated for both
light and dark periods and expressed per animal.
Body Weight, Composition, Length, and Blood Samples
Body weight gain was measured starting at 4- to 5-weeks of age. Body
composition of 7- to 8-week-old ad libitum fed male mice was assessed using
nuclear magnetic resonance spectroscopy using Bruker Minispec q10 (Bruker
Optics, Billerica, MA). For nose-to-anus body length measurements, 7- to
8-week-oldmalemice weremanually immobilized and gently extended to their
full length. All body length measurements were performed by the same inves-
tigator. Tail vein blood was collected during morning hours (9–10 a.m.) and
assayed for glucose (One Touch Ultra, Lifescan, Milpitas, California) and
insulin levels (Ultra Sensitive Rat Insulin ELISA-kit, Crystal Chem. Inc.,
Downers Grove, Illinois) from ad libitum fed 5- to 6-week-old male mice.
Hyperinsulinemic-Euglycemic Clamp
Hyperinsulinemic-euglycemic clamps were performed as previously
described (Hill et al., 2010). Age-matched and similar body weight MC4R
null and reactivated ChAT-Cre, loxTB MC4R, and Phox2b-Cre, loxTB MC4R
mice were used to avoid the confounding influence of body weight on results.
For a detailed description, see the Supplemental Experimental Procedures.
Statistical Methods
Statistical analysis was carried out using GraphPad5 (GraphPad, San Diego,
California) software. Statistical analysis for GIR during hyperinsulinemic-eugly-
cemic clamp was carried out by using two-way, repeated-measures ANOVA,
followed by Bonferroni post test to compare replicate means. All other data
sets were analyzed by one-way ANOVA, followed by post hoc Student-New-
man-Keuls test. All data are presented as mean ± SEM; p value less than
0.05 was considered statistically significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
at doi:10.1016/j.cmet.2011.01.010.c.
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